International Journal of Radiation Oncology * Biology * Physics
Volume 48, Issue 4 , Pages 951-957 , 1 November 2000

Local-regional control in breast cancer patients with a possible genetic predisposition

Presented at the 1999 ASTRO meeting, San Antonio, Texas, October 1999.

  • Laura M Freedman, M.D.

      Affiliations

    • Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
    • ,
  • Thomas A Buchholz, M.D.

      Affiliations

    • Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
    • Corresponding Author InformationReprint requests to: Thomas A. Buchholz, Department of Radiation Oncology, Box 97, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030. Tel.: (713) 792-3400; Fax: (713) 794-5573
    • ,
  • Howard D Thames, Ph.D.

      Affiliations

    • Department of Biomathematics, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
    • ,
  • Eric A Strom, M.D.

      Affiliations

    • Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
    • ,
  • Marsha D McNeese, M.D.

      Affiliations

    • Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
    • ,
  • Gabriel N Hortobagyi, M.D.

      Affiliations

    • Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
    • ,
  • S.Eva Singletary, M.D.

      Affiliations

    • Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; USA
    • ,
  • Keith M Heaton, M.D.

      Affiliations

    • Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; USA
    • Department of Surgical Oncology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA
    • ,
  • Kelly K Hunt, M.D.

      Affiliations

    • Department of Surgical Oncology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA

,Accepted 21 June 2000.

References 

  1. Kirchweger R, Zeillinger R, Schneeberger C, et al.  Patterns of allele losses suggest the existence of five distinct regions of LOH on chromosome 17 in breast cancer. Int J Cancer. 1994;56:193–199
  2. Collins N, McManus R, Wooster R, et al.  Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene. 1995;10(8):1673–1675
  3. American Joint Committee on Cancer. AJCC cancer staging manual. Philadelphia, PA: Lippincott-Raven; 1997.
  4. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:547–581
  5. Cox DR. Regression models and life tables. J R Stat Soc B 1972;34:187–202.
  6. Meric F, Ross MI, Mirza NQ; et al. Breast conservation surgery: Long-term results from a single institution. Brst Cancer Res Treat 1999;57(1):49 (#165).
  7. Shattuck-Eidens D, Oliphant A, McClure M, et al.  BRCA1 sequence analysis in women at high risk for susceptibility mutations. JAMA. 1997;278:1242–1250
  8. Chabner E, Nixon A, Gelman R, et al.  Family history and treatment outcome in young women after breast-conserving surgery and radiation therapy for early-stage cancer. J Clin Oncol. 1998;16:2045–2051
  9. Haas JA, Schulta DJ, Peterson ME, et al.  An analysis of age and family history on outcome after breast-conservation treatment (The University of Pennsylvania experience). Cancer J Sci Am. 1998;4:308–315
  10. Harrold EV, Turner BC, Marloff ET, et al.  Local recurrence in the conservatively treated breast cancer patient (A correlation with age and family history). Cancer J Sci Am. 1988;4:302–307
  11. Turner BC, Harrold E, Matloff E, et al.  BRCA1/BRCA2 germline mutations in locally recurrent breast cancer patients after lumpectomy and radiation therapy (Implications for breast-conserving management in patients with BRCA1/BRCA2 mutations). J Clin Oncol. 1999;17:3017–3024
  12. Pierce L, Strawderman M, Narod S; et al. No deleterious effects of radiotherapy in women who are heterozygote for a BRCA-1 or BRCA-2 mutation following breast-conserving therapy. Proc Am Soc Clin Oncol 1999 (#326).
  13. Robson M, Levin D, Federici M, et al.  Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations. J Natl Cancer Inst. 1999;91:2112–2117
  14. Breast Cancer Linkage Consortium. Pathology of familial breast cancer: Differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet 1997;349:1505–1510.
  15. Verhoog LC, Brekelmans CTM, Seynaeve C; et al. Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet 1998;351:316–321.
  16. Phillips KA, Nichol K, Ozcelik H, et al.  Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations. J Natl Cancer Inst. 1999;91:469–473
  17. Jóhannsson Ó, Ranstam J, Borg Å, Olsson H. Survival of BRCA1 breast and ovarian cancer patients (A population-based study from southern Sweden). J Clin Oncol. 1998;16:397–404
  18. Lee JS, Wacholder S, Struewing JP, et al.  Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst. 1999;91:259–263
  19. Sharan SK, Morimatsu M, Albrecht U, et al.  Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature. 1997;386:804–810
  20. Gowen LC, Avrutskaya AV, Latour AM, et al.  BRCA1 required for transcription-coupled repair of oxidative DNA damage. Science. 1998;281:1009–1012
  21. Zhong Q, Chen CF, Li S, et al.  Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. Science. 1999;285(5428):747–750
  22. Morimatsu M, Donoho G, Hasty P. Cells deleted for Brca2 COOH terminus exhibit hypersensitivity to γ-radiation and premature senescence. Cancer Res. 1998;58:3441–3447
  23. Blocher D, Sigut D, Hannan MA. Fibroblasts for ataxia telangiectasia (AT) and AT heterozygotes show an enhanced level of residual DNA double-strand breaks after low dose-rate γ-irradiation as assayed by pulsed field gel electrophoresis. Int J Radiat Biol. 1991;60:791–802
  24. Rao VN, Shao N, Ahmad M, et al.  Antisense RNA to the putative tumor suppressor gene BRCA1 transforms mouse fibroblasts. Oncogene. 1996;13:1–7

PII: S0360-3016(00)00761-6

International Journal of Radiation Oncology * Biology * Physics
Volume 48, Issue 4 , Pages 951-957 , 1 November 2000

Article Tools

* Image Usage & Resolution